1. Home
  2. VIAV vs IOVA Comparison

VIAV vs IOVA Comparison

Compare VIAV & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$35.19

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$10.18

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
IOVA
Founded
1923
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
1.7B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
VIAV
IOVA
Price
$35.19
$10.18
Analyst Decision
Strong Buy
Buy
Analyst Count
8
10
Target Price
$32.66
$9.00
AVG Volume (30 Days)
3.6M
13.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$1,518,300,000.00
N/A
Revenue This Year
$37.78
$47.74
Revenue Next Year
$10.64
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
40.03
N/A
52 Week Low
$12.05
$1.76
52 Week High
$60.43
$10.98

Technical Indicators

Market Signals
Indicator
VIAV
IOVA
Relative Strength Index (RSI) 44.12 72.59
Support Level $34.83 $3.57
Resistance Level $35.61 N/A
Average True Range (ATR) 1.83 0.47
MACD -0.09 0.06
Stochastic Oscillator 30.46 72.29

Price Performance

Historical Comparison
VIAV
IOVA

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: